Skip to content

Clinical trials

Phase 3 Skin Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Skin Diseases Phase: Phase 3 Country / region: United States Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20091
20104
20122
20133
20172
20185
20193
20206
20212
20235
20244
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Recruiting5
Active, not recruiting4
Withdrawn2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company7
Incyte Corporation6
Pfizer6
Amgen5
MoonLake Immunotherapeutics AG4
Graceway Pharmaceuticals, LLC3
Novartis Pharmaceuticals3
Galderma R&D2
Sun Pharmaceutical Industries, Inc.2
Verrica Pharmaceuticals Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Skin Diseases46
Dermatitis13
Eczema13
Dermatitis, Atopic11
Psoriasis7
Hidradenitis Suppurativa6
Keratosis, Actinic6
Immune System Diseases5
Pruritus5
Skin Diseases, Eczematous5

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.